Gene Therapy with Cytosine Deaminase and Endostatin Fusion Gene Mediated by Endothelial Progenitor Cells in Hepatomas

PURPOSE: Gene-targeting therapy provides a novel therapeutic approach for tumor treatment using genetically modified endothelial progenitor cells (EPCs) as cellular carriers. This study applied EPCs armed with cytosine deaminase (CD) and endostatin (ES) fusion gene in liver cancer to explore its the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Manag Res
Asıl Yazarlar: Zhang, Yue-Lin, Zhou, Tan-Yang, Ai, Jing, Chen, Sheng-Qun, Chen, Feng, Nie, Chun-Hui, Chen, Xin-Hua, Zhou, Guan-Hui, Wang, Hong-Liang, Zhu, Tong-Yin, Wang, Bao-Quan, Yu, Zi-Niu, Jing, Li, Wu, Li-Ming, Zheng, Shu-Sen, Sun, Jun-Hui
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove 2020
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7198450/
https://ncbi.nlm.nih.gov/pubmed/32431545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S245998
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller